Glutathione: A key player in autoimmunity

Autoimmunity Reviews

Volumn 8, Issue 8, 2009, Pages 697-701

  Perricone, Carlo ^a   De Carolis, Caterina ^b   Perricone, Roberto ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Glutathione; GSH; Immunology; Oxidative stress; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; AURANOFIN; AUROTHIOMALATE; CATALASE; GLUTAMINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ALCOHOL LIVER DISEASE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CANCER RISK; CYSTIC FIBROSIS; DEGENERATIVE DISEASE; DIETARY INTAKE; DISEASE COURSE; DNA POLYMORPHISM; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; HUMAN; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; LIVER DISEASE; MUSCULAR DYSTROPHY; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN BINDING; RESPIRATORY DISTRESS SYNDROME; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; WERNER SYNDROME;

ANTIOXIDANTS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; COMPLEMENT SYSTEM PROTEINS; GLUTATHIONE; HUMANS; INFLAMMATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 67349146993     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.020     Document Type: Review

References (40)

1. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39 (2007) 44-84
2. Kalpakcioglu B., and Senel K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol 27 (2008) 141-145
3. Halliwell B., and Gutteridge J.M. Free radicals in biology and medicine (1996), Clarendon Press, Oxford, UK
4. Halliwell B., and Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 57 (1993) 715S-724S
5. Gambhir J.K., Lali P., and Jain A.K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30 (1997) 351-355
6. Fernandez D., and Perl A. Metabolic control of T cell activation and death in SLE. Autoimmun Rev 8 (2009) 184-189
7. Dimitrov J.D., Vassilev T.L., Andre S., Kaveri S.V., and Lacroix-Desmazes S. Functional variability of antibodies upon oxidative processes. Autoimmun Rev 7 (2008) 574-578
8. Crane F.L., and Low H. Reactive oxygen species generation at the plasma membrane for antibody control. Autoimmun Rev 7 (2008) 518-522
9. Faulk W.P., and McIntyre J.A. Prologue to autoimmunity forum: autoimmunity reviews on redox signaling. Autoimmun Rev 7 (2008) 515-517
10. Pastore A., Federici G., Bertini E., and Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 333 (2003) 19-39
11. Dröge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.P., et al. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 8 (1994) 1131-1138
12. Fratelli M., Demol H., Puype M., Casagrande S., Eberini I., Salmona M., et al. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci U S A 99 (2002) 3505-3510
13. Hayes J.D., and McLellan L.I. Glutathione and glutathione-dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radic Res 31 (1999) 273-300
14. Bursell S.E., and King G.L. The potential use of glutathionyl haemoglobin as a clinical marker of oxidative stress. Clin Chem 46 (2000) 145-146
15. Ortona E., Margutti P., Matarrese P., Franconi F., and Malorni W. Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun Rev 7 (2008) 579-584
16. Droge W., Pottmeyer-Gerber C., Schmidt H., and Nick S. Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology 172 (1986) 151-156
17. Gmunder H., and Droge W. Differential effects of glutathione depletion on T cell subsets. Cell Immunol 138 (1991) 229-237
18. Staal F.J., Roederer M., Herzenberg L.A., and Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor kB and transcription of immunodeficiency virus. Proc Natl Acad Sci U S A 87 (1990) 9943-9947
19. Mihm S., Galter D., and Droge W. Modulation of transcription factor NF-kB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J 9 (1995) 246-252
20. Tewes F., Bol G.F., and Brigelius-Flohe R. Thiol modulation inhibits the interleukin-1-mediated activation of an IL-1 receptor associated protein kinase and NF-kB. Eur J Immunol 27 (1997) 3015-3022
21. Arrigo A.P. Gene expression and the thiol redox state. Free Radic Biol Med 27 (1999) 936-944
22. Kim H.J., Barajas B., Chan R.C., and Nel A.E. Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: implications for systemic disease and immunosenescence. J Allergy Clin Immunol 119 (2007) 1225-1233
23. Collard C.D., Vakeva A., Bukusoglu C., Zund G., Sperati C.J., Colgan S.P., et al. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 96 (1997) 326-333
24. Collard C.D., Agah A., and Stahl G.L. Complement activation following reoxygenation of hypoxic human endothelial cells: role of intracellular reactive oxygen species, NF-kB and new protein synthesis. Immunopharmacology 39 (1998) 39-50
25. Vogt W., and Hesse D. Activation of the fifth component of human complement by oxygen-derived free radicals and by methionine oxidizing agents: a comparison. Immunobiology 184 (1992) 384-391
26. Wilhelm D., Bender K., Knebel A., and Angel P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol Cell Biol 17 (1997) 4792-4800
27. Peng H., Takano T., Papillon J., Bijian K., Khadir A., and Cybulsky A.V. Complement activates the c-jun N-terminal kinase/stress-activated protein kinase in glomerular epithelial cells. J Immunol 169 (2002) 2594-2601
28. Townsend D.M., Tew K.D., and Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 57 (2003) 145-155
29. Burek C.L., and Rose N.R. Autoimmune thyroiditis and ROS. Autoimmun Rev 7 (2008) 530-537
30. Griffiths H.R. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?. Autoimmun Rev 7 (2008) 544-549
31. Kurien B.T., and Scofield R.H. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 7 (2008) 567-573
32. Maurice M.M., Nakamura H., van der Voort E.A., van Vliet A.I., Staal F.J., Tak P.P., et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol 158 (1997) 1458-1465
33. Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A 94 (1997) 1967-1972
34. Buhl R., Jaffe H.A., Holroyd K.J., Wells F.B., Mastrangeli A., Saltini C., et al. Systemic glutathione deficiency in symptom-free HIV seropositive individuals. Lancet 2 (1989) 1294-1298
35. Matsuura E., Hughes G.R., and Khamashta M.A. Oxidation of LDL and its clinical implication. Autoimmun Rev 7 (2008) 558-566
36. Samiec P.S., Drews-Botsch C., Flagg E.W., Kurtz J.C., Sternberg Jr. P., Reed R.L., et al. Glutathione in human plasma: decline in association with ageing, age-related macular degeneration, and diabetes. Free Radic Biol Med 24 (1998) 699-704
37. Sukkar S.G., and Rossi E. Oxidative stress and nutritional prevention in autoimmune rheumatic diseases. Autoimmun Rev 3 (2004) 199-206
38. Witschi A., Reddy S., Stofer B., and Lauterburg B.H. The systemic availability of oral glutathione. Eur J Clin Pharmacol 43 (1992) 667-669
39. Hassan M.Q., Hadi R.A., Al-Rawi Z.S., Padron V.A., and Stohs S.J. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol 21 (2001) 69-73
40. Zifman E., Amital H., Gilburd B., and Shoenfeld Y. Antioxidants and smoking in autoimmune disease-opposing sides of the seesaw?. Autoimmun Rev 8 (2008) 165-169